Application:LG100754 (UVI 2112) is a modulator of RXR dimers. LG100754 acts as an antagonist of the homodimeric RXR:RXR, but as an agonist of the heterodimeric RXR:PPARα and RXR:PPARγ. LG100754 is an insulin sensitizer acting through RXR.
Specifications and Purity: ≥98%
Molecular Formula: C26H36O3
Molecular Weight: 396.56
PubChem CID: 6442223
Isomeric SMILES: CCCOC1=CC2=C(C=C1/C(=C/C=C/C(=C/C(=O)O)/C)/C)C(CCC2(C)C)(C)C
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/L286924-SCI_26d3a00e842c4cac6336713586ccf5ee.pdf
- UPC:
- 42202002
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- L286924-1mg
- CAS:
- 180713-37-5
- Product Size:
- 1mg
- Precautionary Statement Codes:
- P264
akash.verma@cenmed.com
(732) 447-1115





